Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leitengshu in MTX-inadequate responder postmenopausal RA – Phase II
CTR20201397Phase 2Completed
- Sponsor
- Shanghai Institute of Materia Medica
- Start
- Jul 2020
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxytriptolide in rheumatoid arthritis (RA), sponsored by Shanghai Institute of Materia Medica. Started Jul 2020; status: completed.
02
Drugs
hydroxytriptolide
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20201397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201397.